MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypes
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 180, Issue 1, Pages 73-86
Publisher
Springer Science and Business Media LLC
Online
2020-01-17
DOI
10.1007/s10549-020-05532-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
- (2018) Antonio C. Wolff et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Discordance of the PAM50 Intrinsic Subtypes Compared with IHC-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance
- (2018) Hee Kyung Kim et al. Cancer Research and Treatment
- High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes
- (2017) Meng Pu et al. TUMOR BIOLOGY
- Down-regulation of MRPS23 inhibits rat breast cancer proliferation and metastasis
- (2017) Yan Gao et al. Oncotarget
- Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin
- (2014) Katherine A. Hoadley et al. CELL
- Proteogenomic characterization of human colon and rectal cancer
- (2014) Bing Zhang et al. NATURE
- An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer
- (2014) Michael L Gatza et al. NATURE GENETICS
- Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients
- (2013) M. J. Engstrøm et al. BREAST CANCER RESEARCH AND TREATMENT
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- Proteomic Changes Resulting from Gene Copy Number Variations in Cancer Cells
- (2010) Tamar Geiger et al. PLoS Genetics
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
- (2010) Fiona M. Blows et al. PLOS MEDICINE
- Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescencein situhybridization and microarray-based CGH analysis
- (2009) Caterina Marchiò et al. JOURNAL OF PATHOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started